1. Kipps T.J., Stevenson F.K., Wu C.J., Croce C.M., Packham G., Wierda W.G. et al. Chronic lymphocytic leukaemia // Nat. Rev. Dis. Primers. 2017. Vol. 3. Article ID 16096.
2. Sant M., Allemani C., Tereanu C., De Angelis R., Capocaccia R., Visser O. et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project // Blood. 2010. Vol. 116, N 19. P. 3724–3734.
3. Chiorazzi N., Rai K.R., Ferrarini M. Chronic lymphocytic leukemia // N. Engl. J. Med. 2005. Vol. 352, N 8. P. 804–815.
4. Crowther-Swanepoel D., Houlston R.S. Genetic variation and risk of chronic lymphocytic leukaemia // Semin. Cancer Biol. 2010. Vol. 20, N 6. P. 363–369.
5. Speedy H.E., Sava G., Houlston R.S. Inherited susceptibility to CLL // Adv. Exp. Med. Biol. 2013. Vol. 792. P. 293–308.
6. Law P.J., Berndt S.I., Speedy H.E., Camp N.J., Sava G.P., Skibola C.F. et al. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia // Nat. Commun. 2017. Vol. 8. Article ID 14175.
7. Hallek M., Cheson B.D., Catovsky D., Caligaris-Cappio F., Dighiero G., Dohner H. et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL // Blood. 2018. Vol. 131, N 25. P. 2745–2760.
8. Scarfo L., Ferreri A.J., Ghia P. Chronic lymphocytic leukaemia // Crit. Rev. Oncol. Hematol. 2016. Vol. 104. P. 169–182.
9. Fischer K., Hallek M. Optimizing frontline therapy of CLL based on clinical and biological factors // Hematology Am. Soc. Hematol. Educ. Program. 2017. Vol. 2017, N 1. P. 338–345.
10. Damle R.N., Ghiotto F., Valetto A., Albesiano E., Fais F., Yan X.J. et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes // Blood. 2002. Vol. 99, N 11. P. 4087–4093.
11. Crassini K., Stevenson W.S., Mulligan S.P., Best O.G. Molecular pathogenesis of chronic lymphocytic leukaemia // Br. J. Haematol. 2019. Vol. 186, N 5. P. 668–684.
12. Herishanu Y., Katz B.Z., Lipsky A., Wiestner A. Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications // Hematol. Oncol. Clin. North Am. 2013. Vol. 27, N 2. P. 173–206.
13. Dearden C. Disease-specific complications of chronic lymphocytic leukemia // Hematology Am. Soc. Hematol. Educ. Program. 2008. P. 450–456.
14. Chiorazzi N., Stevenson F.K. Celebrating 20 Years of IGHV Mutation Analysis in CLL // Hemasphere. 2020. Vol. 4, N 1. P. e334.
15. Chiorazzi N., Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor // Annu. Rev. Immunol. 2003. Vol. 21. P. 841–894.
16. Stevenson F.K., Forconi F., Packham G. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia // Semin. Hematol. 2014. Vol. 51, N 3. P. 158–167.
17. Wiestner A. BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma // Hematology Am. Soc. Hematol. Educ. Program. 2014. Vol. 2014, N 1. P. 125–134.
18. Gemenetzi K., Agathangelidis A., Zaragoza-Infante L., Sofou E., Papaioannou M., Chatzidimitriou A. et al. B cell receptor immunogenetics in B cell lymphomas: immunoglobulin genes as key to ontogeny and clinical decision making // Front. Oncol. 2020. Vol. 10. P. 67.
19. Monroe J.G., Dorshkind K. Fate decisions regulating bone marrow and peripheral B lymphocyte development // Adv. Immunol. 2007. Vol. 95. P. 1–50.
20. LeBien T.W., Tedder T.F. B lymphocytes: how they develop and function // Blood. 2008. Vol. 112, N 5. P. 1570–1580.
21. Lefranc M.-P., Lefranc Ge. The Immunoglobulin Factsbook. San Diego : Academic Press, 2001. 457 p.
22. Alt F.W., Zhang Y., Meng F.L., Guo C., Schwer B. Mechanisms of programmed DNA lesions and genomic instability in the immune system // Cell. 2013. Vol. 152, N 3. P. 417–429.
23. Melchers F., Karasuyama H., Haasner D., Bauer S., Kudo A., Sakaguchi N. et al. The surrogate light chain in B-cell development // Immunol. Today. 1993. Vol. 14, N 2. P. 60–68.
24. Victora G.D., Nussenzweig M.C. Germinal centers // Annu. Rev. Immunol. 2012. Vol. 30. P. 429–457.
25. Zhang Y., Garcia-Ibanez L., Toellner K.M. Regulation of germinal center B-cell differentiation // Immunol. Rev. 2016. Vol. 270, N 1. P. 8–19.
26. Hardy R.R., Hayakawa K. B cell development pathways // Annu. Rev. Immunol. 2001. Vol. 19. P. 595–621.
27. Seifert M., Kuppers R. Human memory B cells // Leukemia. 2016. Vol. 30, N 12. P. 2283–2292.
28. Casola S., Otipoby K.L., Alimzhanov M., Humme S., Uyttersprot N., Kutok J.L. et al. B cell receptor signal strength determines B cell fate // Nat. Immunol. 2004. Vol. 5, N 3. P. 317–327.
29. Peled J.U., Kuang F.L., Iglesias-Ussel M.D., Roa S., Kalis S.L., Goodman M.F. et al. The biochemistry of somatic hypermutation // Annu. Rev. Immunol. 2008. Vol. 26. P. 481–511.
30. Xu Z., Zan H., Pone E.J., Mai T., Casali P. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond // Nat. Rev. Immunol. 2012. Vol. 12, N 7. P. 517–531.
31. Stavnezer J., Schrader C.E. IgH chain class switch recombination: mechanism and regulation // J Immunol. 2014. Vol. 193, N 11. P. 5370–5378.
32. Martin F., Kearney J.F. Marginal-zone B cells // Nat. Rev. Immunol. 2002. Vol. 2, N 5. P. 323–335.
33. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells // Annu. Rev. Immunol. 2009. Vol. 27. P. 267–285.
34. Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E. et al. Human blood IgM «memory» B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire // Blood. 2004. Vol. 104, N 12. P. 3647–3654.